Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOD1 | Q9Y239 | 3/20 | 0.68 |
| ▸ | NMT1 | P30419 | 5/20 | 0.48 |
| ▸ | NMT2 | O60551 | 4/20 | 0.48 |
| ▸ | TLR2 | O60603 | 1/20 | 0.47 |
| ▸ | GHSR | Q92847 | 3/20 | 0.43 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.42 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.42 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.41 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.41 |
| ▸ | LNPEP | Q9UIQ6 | 1/20 | 0.41 |
| ▸ | ROCK2 | O75116 | 3/20 | 0.41 |
| ▸ | PRKACA | P17612 | 1/20 | 0.41 |
| ▸ | AKT3 | Q9Y243 | 1/20 | 0.41 |
| ▸ | HPGDS | O60760 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20653679 | 0.91 | NOD1 (0.55) | NOD1NMT1NMT2TLR2GHSR | |
| SCHEMBL31686179 | 0.91 | NOD1 (0.55) | NOD1NMT1NMT2TLR2GHSR | |
| SCHEMBL21330513 | 0.89 | NOD1 (0.68) | NOD1NMT1NMT2SLC6A5FOLH1 | |
| SCHEMBL6129561 | 0.88 | NOD1 (0.61) | NOD1NMT1NMT2TLR2GHSR | |
| SCHEMBL2508780 | 0.88 | NOD1 (0.61) | NOD1NMT1NMT2TLR2GHSR | |
| SCHEMBL23230082 | 0.85 | NOD1 (0.50) | NOD1NMT1NMT2GHSRERAP2 | |
| SCHEMBL31181276 | 0.85 | NOD1 (0.50) | NOD1NMT1NMT2GHSRERAP2 | |
| SCHEMBL30340325 | 0.85 | NOD1 (0.50) | NOD1NMT1NMT2GHSRERAP2 | |
| SCHEMBL13363646 | 0.85 | NMT2 (0.52) | NOD1NMT1NMT2TLR2GHSR | |
| SCHEMBL23230081 | 0.84 | NOD1 (0.49) | NOD1NMT1NMT2TLR2GHSR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3239139-A1 | CHEMICAL SYNTHESIS AND ANTI-TUMOR AND ANTI-METASTATIC EFFECTS OF DUAL FUNCTIONAL CONJUGATE | Shenzhen Salubris Pharmaceuticals Co., Ltd (CN) | 2017-11-01 | — | — | EP | disclosed |